Yuki Fukami

1.2k total citations
37 papers, 831 citations indexed

About

Yuki Fukami is a scholar working on Neurology, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuki Fukami has authored 37 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuki Fukami's work include Peripheral Neuropathies and Disorders (22 papers), Hereditary Neurological Disorders (13 papers) and Vasculitis and related conditions (7 papers). Yuki Fukami is often cited by papers focused on Peripheral Neuropathies and Disorders (22 papers), Hereditary Neurological Disorders (13 papers) and Vasculitis and related conditions (7 papers). Yuki Fukami collaborates with scholars based in Japan, Singapore and Malaysia. Yuki Fukami's co-authors include Nobuhiro Yuki, Constance Manso, Maya Belghazi, Jérôme Devaux, Yumako Miura, Masahisa Katsuno, Haruki Koike, Masahiro Iijima, Hiu Yi Wong and Norito Kokubun and has published in prestigious journals such as Brain, Neurology and Stroke.

In The Last Decade

Yuki Fukami

36 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuki Fukami Japan 15 573 416 141 139 123 37 831
Miquel Navas‐Madroñal Spain 11 335 0.6× 217 0.5× 53 0.4× 83 0.6× 68 0.6× 13 650
Ryoji Nishi Japan 11 235 0.4× 164 0.4× 73 0.5× 108 0.8× 108 0.9× 22 430
Philippe Petiot France 13 408 0.7× 207 0.5× 104 0.7× 52 0.4× 55 0.4× 26 681
Emmanuel Ellie France 14 312 0.5× 160 0.4× 115 0.8× 51 0.4× 92 0.7× 36 682
Junichi Murata Japan 17 493 0.9× 274 0.7× 57 0.4× 120 0.9× 39 0.3× 46 928
Stefan Probst‐Cousin Germany 16 309 0.5× 127 0.3× 82 0.6× 118 0.8× 51 0.4× 34 745
Caterina Giannini United States 9 415 0.7× 90 0.2× 126 0.9× 103 0.7× 43 0.3× 13 868
Satsuki Mitsuma Japan 13 624 1.1× 326 0.8× 51 0.4× 17 0.1× 56 0.5× 16 758
Susanna Ruggero Italy 16 378 0.7× 121 0.3× 101 0.7× 22 0.2× 166 1.3× 31 844
Beverly McElroy United States 8 760 1.3× 298 0.7× 32 0.2× 14 0.1× 78 0.6× 10 1.0k

Countries citing papers authored by Yuki Fukami

Since Specialization
Citations

This map shows the geographic impact of Yuki Fukami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuki Fukami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuki Fukami more than expected).

Fields of papers citing papers by Yuki Fukami

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuki Fukami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuki Fukami. The network helps show where Yuki Fukami may publish in the future.

Co-authorship network of co-authors of Yuki Fukami

This figure shows the co-authorship network connecting the top 25 collaborators of Yuki Fukami. A scholar is included among the top collaborators of Yuki Fukami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuki Fukami. Yuki Fukami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hane, Masaya, Yuki Fukami, Keisuke Ikegami, et al.. (2025). A highly sensitive quantitative method of polysialic acid reveals its unique changes in brain aging and neuropsychiatric disorders. PubMed. 15(1). 19033–19033.
2.
Fukami, Yuki, Hisatoshi Hanamatsu, Jun‐ichi Furukawa, et al.. (2024). Serum glycobiomarkers for chronic inflammatory demyelinating polyneuropathy. European Journal of Neurology. 32(1). e70023–e70023. 1 indexed citations
3.
Yokoi, Satoshi, et al.. (2024). Guillain-Barré syndrome with overlap between the finger drop variant and acute bulbar palsy: a case report. BMC Neurology. 24(1). 411–411. 2 indexed citations
4.
Mori, Yasuko, Nobuaki Yoshikura, Yuki Fukami, et al.. (2024). Anti-contactin-associated protein 1 antibody-positive nodopathy presenting with central nervous system symptoms. Journal of Neuroimmunology. 394. 578420–578420. 1 indexed citations
5.
Ikeda, Shohei, Minoru Tomita, Yu Mori, et al.. (2022). Demyelinating Neuropathy with Markedly Elevated Serum IgG4 Levels and Anti-Contactin 1 IgG4 Antibody. Internal Medicine. 62(9). 1341–1344. 2 indexed citations
6.
Koike, Haruki, Ryoji Nishi, Satoru Yagi, et al.. (2022). A Review of Anti-IL-5 Therapies for Eosinophilic Granulomatosis with Polyangiitis. Advances in Therapy. 40(1). 25–40. 11 indexed citations
7.
Koike, Haruki, et al.. (2022). In vivo visualization of eosinophil secretion in eosinophilic granulomatosis with polyangiitis: An ultrastructural study. Allergology International. 71(3). 373–382. 18 indexed citations
8.
Fukami, Yuki, et al.. (2022). Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis. Muscle & Nerve. 66(2). 175–182. 5 indexed citations
9.
Koike, Haruki, et al.. (2022). Dosage effects of PMP22 on nonmyelinating Schwann cells in hereditary neuropathy with liability to pressure palsies. Neuromuscular Disorders. 32(6). 503–511. 6 indexed citations
10.
Koike, Haruki, Ryoji Nishi, Ken Ohyama, et al.. (2022). ANCA-Associated Vasculitic Neuropathies: A Review. Neurology and Therapy. 11(1). 21–38. 28 indexed citations
11.
Shimizu, Shinobu, Masahiro Iijima, Yuki Fukami, et al.. (2020). Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial. JMIR Research Protocols. 9(4). e17117–e17117. 24 indexed citations
12.
Koike, Haruki, Yuki Fukami, Ryoji Nishi, et al.. (2020). Ultrastructural mechanisms of macrophage-induced demyelination in Guillain-Barré syndrome. Journal of Neurology Neurosurgery & Psychiatry. 91(6). 650–659. 48 indexed citations
13.
14.
Shahrizaila, Nortina, et al.. (2017). Electrodiagnosis of reversible conduction failure in Guillain–Barré syndrome. Muscle & Nerve. 56(5). 919–924. 22 indexed citations
15.
Fukami, Yuki, Toshio Ariga, Mitsunori Yamada, & Nobuhiro Yuki. (2017). Brain Gangliosides in Alzheimer’s Disease: Increased Expression of Cholinergic Neuron-Specific Gangliosides. Current Alzheimer Research. 14(6). 586–591. 26 indexed citations
16.
Hacohen, Yael, Yukihiro Nishimoto, Yuki Fukami, et al.. (2016). Paediatric brainstem encephalitis associated with glial and neuronal autoantibodies. Developmental Medicine & Child Neurology. 58(8). 836–841. 24 indexed citations
17.
Fukami, Yuki, et al.. (2015). Using Xenopus tissue cultures for the study of myasthenia gravis pathogenesis. Developmental Biology. 408(2). 244–251. 6 indexed citations
18.
Wong, Hiu Yi, Yuki Fukami, Makoto Sudo, et al.. (2015). Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy. Journal of Neurology Neurosurgery & Psychiatry. 87(3). 275–279. 30 indexed citations
19.
Miura, Yumako, Jérôme Devaux, Yuki Fukami, et al.. (2015). Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia. Brain. 138(6). 1484–1491. 155 indexed citations
20.
Yuki, Nobuhiro, et al.. (2014). GD1b-specific antibodies may bind to complex of GQ1b and GM1, causing ataxia. Journal of Neurology. 261(8). 1565–1569. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Miquel Navas‐Madroñal Breakdown of academic impact, for papers by Ryoji Nishi Breakdown of academic impact, for papers by Philippe Petiot Breakdown of academic impact, for papers by Emmanuel Ellie Breakdown of academic impact, for papers by Junichi Murata Breakdown of academic impact, for papers by Stefan Probst‐Cousin Breakdown of academic impact, for papers by Caterina Giannini Breakdown of academic impact, for papers by Satsuki Mitsuma Breakdown of academic impact, for papers by Susanna Ruggero Breakdown of academic impact, for papers by Beverly McElroy
Rankless by CCL
2026